B. Riley Securities Bolsters Healthcare Banking with Industry Veteran Amid Sector Shift

New York, NY – November 10, 2025 – B. Riley Securities has appointed Greg Crooks as Managing Director, bolstering its healthcare investment banking team at a time of significant transformation for the industry. The move signals a strategic commitment to the sector as companies grapple with patent expirations, rapidly evolving technologies – particularly in artificial intelligence – and a resurgence in strategic mergers and acquisitions.

Crooks brings over 20 years of experience to B. Riley, having previously held Managing Director positions at both BTIG and Cantor Fitzgerald. He specializes in advising companies across the biopharmaceutical, medical device, and healthcare technology landscapes. B. Riley believes his deep industry knowledge and extensive network will be invaluable as it seeks to expand its presence in this dynamic sector.

“We are thrilled to welcome Greg to the team,” stated a B. Riley spokesperson. “His proven track record of success and deep understanding of the healthcare industry will be instrumental in helping our clients navigate the complex challenges and opportunities they face.”

A Shifting Healthcare Landscape Demands Expertise

The timing of Crooks’ appointment is particularly noteworthy. The healthcare industry is undergoing a period of rapid change, driven by several key factors. Patent cliffs are forcing pharmaceutical giants to seek out new growth opportunities through acquisitions and licensing deals. Simultaneously, advancements in artificial intelligence are disrupting traditional healthcare models, creating both challenges and opportunities for innovation.

“Companies are under immense pressure to replenish their pipelines and adapt to the changing technological landscape,” explained an industry analyst. “Those who can successfully navigate these challenges will be well-positioned for long-term success.”

According to recent reports, M&A activity in the healthcare sector is picking up after a slower 2024. While deal volume remains below pre-pandemic levels, there's a growing sense of optimism as economic conditions stabilize and interest rates potentially decline. Strategic acquisitions, particularly those focused on innovative technologies and niche therapeutic areas, are becoming increasingly common.

AI and the Future of Healthcare Investment

Artificial intelligence is poised to be a major driver of growth in the healthcare sector in the coming years. From drug discovery and development to diagnostics and patient care, AI is transforming every aspect of the industry. This is attracting significant investment from venture capital firms and strategic acquirers alike.

“We’re seeing a surge in funding for AI-powered healthcare startups,” noted a venture capital investor specializing in digital health. “Companies that can leverage AI to improve patient outcomes and reduce healthcare costs are particularly attractive.”

However, the adoption of AI in healthcare also presents challenges, including regulatory hurdles, data privacy concerns, and ethical considerations. Companies will need to carefully navigate these issues to ensure that AI is used responsibly and effectively.

B. Riley's Strategic Response

B. Riley’s expansion of its healthcare banking team, with the addition of Crooks, is a clear indication that the firm is positioning itself to capitalize on these trends. By bringing on an experienced industry veteran, B. Riley aims to provide its clients with the expertise and guidance they need to navigate the complex landscape and seize emerging opportunities.

“B. Riley recognizes the importance of having a strong presence in the healthcare sector,” said a source familiar with the firm’s strategy. “The firm is committed to investing in the resources and talent needed to serve its clients effectively.”

A Sector Poised for Consolidation and Innovation

The healthcare industry is expected to see continued consolidation in the coming years, as companies seek to gain scale and improve efficiency. Strategic acquisitions will likely focus on areas such as specialty pharmaceuticals, medical devices, and healthcare technology.

“We expect to see a wave of M&A activity in the healthcare sector,” said an industry analyst. “Companies will be looking to acquire innovative technologies, expand their product portfolios, and consolidate their market positions.”

In addition to consolidation, the healthcare industry is also poised for continued innovation. Advancements in areas such as genomics, personalized medicine, and digital health are creating new opportunities for growth and disruption.

“The healthcare industry is at an inflection point,” said a venture capital investor. “We’re seeing a convergence of technology, innovation, and investment that is transforming the way healthcare is delivered.”

B. Riley’s strategic investment in its healthcare banking team, with the addition of Greg Crooks, signals a commitment to helping its clients navigate this dynamic landscape and capitalize on the opportunities that lie ahead. The firm is well-positioned to serve as a trusted advisor to companies seeking to grow, innovate, and succeed in the evolving healthcare industry. The firm’s recent engagements in follow-on and ATM offerings demonstrate active participation in financing crucial growth for healthcare clients.

As one anonymous industry source noted, “The landscape is changing rapidly, and firms like B. Riley that can adapt and provide specialized expertise will be the ones that thrive.”